Cargando…
Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose?
The prevalence of smell loss in Parkinson’s Disease (PD) patients greatly exceeds that of the characteristic motor symptoms defining the disease by several years. One hypothesis of the cause of PD states that it is initiated in the olfactory bulb — the critical first central processing stage of the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649011/ https://www.ncbi.nlm.nih.gov/pubmed/36357427 http://dx.doi.org/10.1038/s41531-022-00425-5 |
_version_ | 1784827707180187648 |
---|---|
author | Arshamian, Artin Iravani, Behzad Lundström, Johan N. |
author_facet | Arshamian, Artin Iravani, Behzad Lundström, Johan N. |
author_sort | Arshamian, Artin |
collection | PubMed |
description | The prevalence of smell loss in Parkinson’s Disease (PD) patients greatly exceeds that of the characteristic motor symptoms defining the disease by several years. One hypothesis of the cause of PD states that it is initiated in the olfactory bulb — the critical first central processing stage of the olfactory system — and that the olfactory nerve might serve as an entry point to the OB for pathogens or environmental components. But what if there was no OB to start with? Recent data demonstrate that cortical, but not peripheral, blindness acts as a protective factor against schizophrenia and other psychotic disorders. We hypothesize that individuals with the rare diagnose Isolated Congential Anosmia (ICA) are immune to PD given that they are born without OBs. If true, it would strongly support the theory that PD might start in the bulb. However, if one could identify even one single PD patient with an established ICA diagnosis with non-existing OBs, a so-called black swan, this would effectively falsify the hypothesis. In this commentary, we model the likely occurrence of such potential comorbidity and we postulate that it is possible to find this black swan; a finding that would falsify a salient hypothesis within the PD research community. |
format | Online Article Text |
id | pubmed-9649011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96490112022-11-14 Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? Arshamian, Artin Iravani, Behzad Lundström, Johan N. NPJ Parkinsons Dis Comment The prevalence of smell loss in Parkinson’s Disease (PD) patients greatly exceeds that of the characteristic motor symptoms defining the disease by several years. One hypothesis of the cause of PD states that it is initiated in the olfactory bulb — the critical first central processing stage of the olfactory system — and that the olfactory nerve might serve as an entry point to the OB for pathogens or environmental components. But what if there was no OB to start with? Recent data demonstrate that cortical, but not peripheral, blindness acts as a protective factor against schizophrenia and other psychotic disorders. We hypothesize that individuals with the rare diagnose Isolated Congential Anosmia (ICA) are immune to PD given that they are born without OBs. If true, it would strongly support the theory that PD might start in the bulb. However, if one could identify even one single PD patient with an established ICA diagnosis with non-existing OBs, a so-called black swan, this would effectively falsify the hypothesis. In this commentary, we model the likely occurrence of such potential comorbidity and we postulate that it is possible to find this black swan; a finding that would falsify a salient hypothesis within the PD research community. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9649011/ /pubmed/36357427 http://dx.doi.org/10.1038/s41531-022-00425-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Comment Arshamian, Artin Iravani, Behzad Lundström, Johan N. Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title | Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title_full | Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title_fullStr | Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title_full_unstemmed | Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title_short | Is congenital anosmia protective for Parkinson’s disease triggered by pathogenic entrance through the nose? |
title_sort | is congenital anosmia protective for parkinson’s disease triggered by pathogenic entrance through the nose? |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649011/ https://www.ncbi.nlm.nih.gov/pubmed/36357427 http://dx.doi.org/10.1038/s41531-022-00425-5 |
work_keys_str_mv | AT arshamianartin iscongenitalanosmiaprotectiveforparkinsonsdiseasetriggeredbypathogenicentrancethroughthenose AT iravanibehzad iscongenitalanosmiaprotectiveforparkinsonsdiseasetriggeredbypathogenicentrancethroughthenose AT lundstromjohann iscongenitalanosmiaprotectiveforparkinsonsdiseasetriggeredbypathogenicentrancethroughthenose |